Epoch Investment Partners Inc. Increases Stock Holdings in Lam Research Corporation $LRCX

Key Points

• Epoch Investment Partners Inc. increased its stake in Lam Research Corporation by 8.2%, owning approximately 1,874,533 shares valued at about $136.3 million as of the end of the first quarter.
• Several hedge funds have also significantly boosted their positions in Lam Research, including Ameriprise Financial, which saw a 950.5% increase in shares during the last quarter.
• Analysts generally hold a positive outlook on Lam Research, with a consensus rating of “Moderate Buy” and an average price target of $107.30, after several upward revisions in price objectives by various brokerage firms.

Epoch Investment Partners Inc. lifted its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 8.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,874,533 shares of the semiconductor company's stock after buying an additional 142,402 shares during the period. Epoch Investment Partners Inc. owned about 0.15% of Lam Research worth $136,279,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of Lam Research by 6.9% during the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock valued at $9,389,358,000 after buying an additional 8,364,375 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of Lam Research by 950.5% during the fourth quarter. Ameriprise Financial Inc. now owns 34,543,915 shares of the semiconductor company's stock valued at $2,495,128,000 after buying an additional 31,255,726 shares during the last quarter. Invesco Ltd. boosted its position in shares of Lam Research by 2.8% during the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock valued at $1,259,947,000 after buying an additional 472,636 shares during the last quarter. Northern Trust Corp boosted its position in shares of Lam Research by 1,067.0% during the fourth quarter. Northern Trust Corp now owns 15,869,244 shares of the semiconductor company's stock valued at $1,146,235,000 after buying an additional 14,509,407 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Lam Research by 6,383.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company's stock valued at $980,500,000 after buying an additional 13,365,317 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on LRCX. Summit Insights cut Lam Research from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Stifel Nicolaus boosted their price objective on Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. Wells Fargo & Company set a $98.00 price objective on Lam Research and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Argus boosted their price objective on Lam Research from $105.00 to $120.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Finally, Morgan Stanley boosted their price objective on Lam Research from $87.00 to $94.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $107.30.

Lam Research Stock Performance

NASDAQ:LRCX opened at $101.28 on Tuesday. The business's 50-day moving average price is $98.57 and its two-hundred day moving average price is $84.75. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $108.02. The stock has a market cap of $128.18 billion, a P/E ratio of 24.35, a PEG ratio of 1.29 and a beta of 1.65. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same quarter last year, the firm posted $1.03 EPS. The company's revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, equities analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.